COM:MERZ
Merz
- Privately Held
Strong global presence in key markets
Diverse product portfolio across aesthetics, therapeutics, and consumer care
Recent successful product approvals (e.g., XEOMIN)
Proactive approach to regulatory compliance (e.g., DSCSA implementation)
High growth potential in line with industry trends
Not the dominant market leader (10% market share)
Past compliance issues with promotional activities
Intense competition in the medical aesthetics industry
Exposure to regulatory risks across multiple jurisdictions
Growth
Revenue Organic
Strong organic growth potential in line with industry CAGR of 9.04%
Revenue Overall
Solid overall revenue growth, supported by market expansion and new product approvals
Profile
Multinational
Strong global presence across multiple regions, including key markets like US, UK, and EU
Clear Market Leader
Significant player with 10% market share, but not the dominant leader
Buy-and-Build Platform
Some evidence of acquisitions, but limited information on recent buy-and-build activities
Resilience
Non-cyclical
Moderate resilience to economic cycles due to mix of essential and discretionary products
Revenue Visibility
Strong revenue visibility with established product lines and recurring treatments
Profitability
Gross Margin
High profit margins indicated in industry analysis for aesthetic treatments
EBITDA Margin
EBITDA margin data not provided
Cash Conversion
Insufficient information to assess cash conversion